Brief: Immunoprecise Antibodies Announces CFO Transition
Sept 19 (Reuters) - Immunoprecise Antibodies Ltd
IPA.O :
* IMMUNOPRECISE ANTIBODIES ANNOUNCES CFO TRANSITION
* IMMUNOPRECISE ANTIBODIES LTD: KRISTIN TAYLOR NAMED INTERIM
CFO
* IMMUNOPRECISE ANTIBODIES LTD: ANNOUNCED THAT IT HAS
ACCEPTED
RESIGNATION OF BRAD MCCONN, CFO, EFFECTIVE SEPTEMBER 29, 2023
Source text for Eikon: ID:nBw7NZhtDa
Further company coverage: IPA.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Mindwalk Holdings
See all newsBrief: Mindwalk Holdings Corp. Announces Leadership Update
MindWalk Holdings Corp reports results for the quarter ended July 31 - Earnings Summary
Canada's MindWalk Q1 net loss widens on higher sales, marketing expenses
MindWalk Holdings Corp expected to post a loss of 8 cents a share - Earnings Preview
Brief: MindWalk Showcases Reefiq™ For Ai Drug Discovery At AMD Advancing Ai